Comparison of Molecular Docking and Molecular Dynamics Simulations of 1,3-Thiazin-4-One with MDM2 Protein

Article Preview

Abstract:

The molecular docking and molecular dynamics simulations studies of 1,3–thiazin–4–one derivative with a bonafide oncogene protein MDM2 (PDB ID: 4HBM) was investigated. Both the docking and dynamics simulations were performed in Schrödinger software suite 2014 using Glide and Desmond modules. The results of docking and dynamics were compared to investigate the possible binding modes of the thiazinone derivative with 4HBM. The tested molecule shows critical interactions with the important amino acid His 96 which is necessary for the inhibition of MDM2 in both docking and dynamic studies.

Info:

Pages:

161-167

Citation:

Online since:

September 2015

Export:

* - Corresponding Author

[1] L.A. Donehower, M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery, J.S. Butel, A. Bradley, L.A. Donehower, M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery, J.S. Butel, A. Bradley, Mice deficient for p.53 are developmentally normal but susceptible to spontaneous tumours, Nature, 356 (1992) 215-221.

DOI: 10.1038/356215a0

Google Scholar

[2] D. Bernard, Y. Zhao, S. Wang, AM-8553: a novel MDM2 inhibitor with a promising outlook for potential clinical development, J. Med. Chem. 55 (2012) 4934–4935.

DOI: 10.1021/jm3007068

Google Scholar

[3] S.A.A. Anand, C. Loganathan, N.S. Thomas, K. Saravanan, A.T. Alphonsa, S. Kabilan, Synthesis, structure prediction, pharmacokinetic properties, molecular docking and antitumor activities of some novel thiazinone derivatives, New J. Chem. 39 (2015) 7120-7129.

DOI: 10.1039/c5nj01369k

Google Scholar

[4] H. Yamashita, K. Ohno, H. Inami, J. Shishikura, S. Sakamoto, M. Okada, T. Yamaguchi, Suppression of fully kindled seizure and retardation of kindling acquisition by YM928 in the rat kindling model of epilepsy, Eur. J. Pharmacol. 494 (2004) 147–154.

DOI: 10.1016/j.ejphar.2004.04.052

Google Scholar

[5] L.D.S. Yadav, A.R. Misra, H. Singh, Ring transformation of Michael adducts of Benzylidene-5-oxazolones and 3-mercapto-s-triazoles to 2,3-dihydro-4H-s-triazolo[3,4-b][1,3] thiazin-4-ones with some antifungal activity, J. Agric. Food Chem. 36 (1988) 633–638.

DOI: 10.1021/jf00081a056

Google Scholar

[6] V.V. Kouznetsov, A.G. Barrio, Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation, Eur. J. Med. Chem. 44 (2009) 3091–3113.

DOI: 10.1016/j.ejmech.2009.02.024

Google Scholar

[7] J. Matysiak, M. Juszczak, M.M. Karpińska, E. Langner, K. Walczak, M.K. Lemieszek, A. Skrzypek, A. Niewiadomy, W. Rzeski, Synthesis of 2-(2,4-dihydroxyphenyl)thieno-1,3-thiazin-4-ones, their lipophilicity and anticancer activity in vitro, Mol. divers. (2015).

DOI: 10.1007/s11030-015-9599-x

Google Scholar

[8] K. Ohno, R. Tsutsumi, N. Matsumoto, H. Yamashita, Y. Amada, J. Shishikura, H.I.S. Yatsugi, M. Okada, S. Sakamoto and T. Yamaguchi, Functional characterization of YM928, a novel moncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist, J. Pharmacol. Exp. Ther. 306 (2003) 66–72.

DOI: 10.1124/jpet.103.049973

Google Scholar

[9] K. Michelsen, J.B. Jordan, J. Lewis , A.M. Long, E. Yang , Y. Rew, J. Zhou , P. Yakowec, P.D. Schnier , X. Huang , L. Poppe, Ordering of the N-terminus of human MDM2 by small molecule inhibitors, J. Am. Chem. Soc. 134 (2012) 17059-17067.

DOI: 10.1021/ja305839b

Google Scholar

[10] Protein Preparation Wizard; Epik version 2.3, 2014; Impact version 5.7, 2014, Schrödinger, LLC, New York.

Google Scholar

[11] Maestro, 2014 release, Schrödinger suite, LLC, New York, 2014.

Google Scholar

[12] W.L. Jorgensen, D.S. Maxwell, J. Tirado–Rives, Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids, J. Am. Chem. Soc. 118 (1996) 11225–11236.

DOI: 10.1021/ja9621760

Google Scholar

[13] LigPrep, version 2.5, 2014, Schrödinger, LLC, New York.

Google Scholar

[14] Glide, version 5.8, 2014, Schrödinger, LLC, New York.

Google Scholar

[15] Desmond Molecular Dynamics System, version 3.1, 2012, D. E. Shaw Research, New York, Maestro–Desmond Interoperability Tools, version 3.1, 2012, Schrödinger, New York.

Google Scholar

[16] W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, M.L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys. 79 (1983) 926–935.

DOI: 10.1063/1.445869

Google Scholar

[17] W.G. Hoover, Canonical dynamics: Equilibrium phase-space distributions, Phys. Rev. A. 31 (1985) 1695–1697.

DOI: 10.1103/physreva.31.1695

Google Scholar

[18] G.J. Martyna, D.J. Tobias, M.L. Klein, Constant pressure molecular dynamics algorithms, J. Chem. Phys. 101 (1994) 4177–4189.

DOI: 10.1063/1.467468

Google Scholar

[19] U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, L.G. Pedersen, A smooth particle mesh Ewald method, J. Chem. Phys. 103 (1995) 8577–8859.

DOI: 10.1063/1.470117

Google Scholar

[20] F. Gonzalez-Lopez de Turiso, D. Sun, Y. Rew, M.D. Bartberger, H.P. Beck, J. Canon, A. Chen, D. Chow, T.L. Correll, X. Huang, L.D. Julian, F. Kayser, M.C. Lo, A.M. Long, D. McMinn, J.D. Oliner, T. Osgood, J.P. Powers, A.Y. Saiki, S. Schneider, P. Shaffer, S.H. Xiao, P. Yakowek, X. Yan, Q. Ye, D. Yu, X. Zhao, J. Zhou, J.C. Medina, S.H. Olson, Rational design and binding mode duality of MDM2-p.53 inhibitors, J. Med. Chem. 56 (2013) 4053–4070.

DOI: 10.1021/jm400293z

Google Scholar